Clinical Trial

Evaluation of the Role of Vitamin D in Reducing the Severity and Duration of Rotavirus Infection in Iraqi Children

Completed
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the effect of vitamin D supplementation on the clinical outcomes including duration and severity of rotavirus-induced gastroenteritis in children that will be admitted to the hospital. And to evaluate the anti-inflammatory effect of vitamin D on the pediatrics with rotavirus gastroenteritis by measuring inflammatory markers such as C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), platelet to lymphocytes ratio (PLR), lymphocytes to monocytes ratio (LMR) and mean platelet volume MPV.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-03; most recent amendment 2025-12-25.
Status change: Active, Not Recruiting → Completed 2025-12-25
Trial Details
NCT Number NCT07167797
Lead Sponsor University of Baghdad
Conditions Rotaviral Gastroenteritis
Enrollment 60 participants
Start Date 2025-01-01
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-12-06 (estimated)
Updated on ClinicalTrials.gov 2025-12-31